Video Shorts

1:16

Unpacking the Future of AI in Oncology

8 months ago

Alexander T. Pearson, MD, PhD

1:22

MRD as a Surrogate End Point in Multiple Myeloma Trials

8 months ago

Marc J. Braunstein, MD, PhD

0:1.44

How HPV Testing Can Fall Through the Cracks in Cervical Cancer

8 months ago

Dana Chase, MD

2:06

FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma

8 months ago

David A. Braun, MD, PhD

1:04

How Butyrate Loss Affects Post-Transplant Outcomes in Myeloma

8 months ago

Pooja Phull, MD

1:03

Could Zanidatamab Replace Trastuzumab As the Gold Standard in First-Line HER2+ Gastric Cancer?

8 months ago

Manish A. Shah, MD

0:34

Role of Bridging Therapy Before CAR T-Cell Therapy in Myeloma

8 months ago

Matthew J. Frigault, MD

1:34

The Importance of HPV Vaccination in Oncology

8 months ago

Maurie Markman, MD

1:09

The Significance of the FDA Approval of Subcutaneous Daratumumab for Smoldering Multiple Myeloma

8 months ago

Peter Voorhees, MD

Laura Alder, MD, Eric K. Singhi, MD, and Paolo Tarantino, MD, PhD.

2:01

Quick Takes: Bridging the Gaps in Brain Mets, Continued

8 months ago

Paolo Tarantino, MD(+2 more)

0:51

Unpacking Real-World Data in mCRC

8 months ago

Rocio Garcia-Carbonero, MD, PhD

Jason Mouabbi, MD, Manmeet Ahluwalia, MD, MBA, FASCO, Laura Alder, MD.

1:45

Quick Takes: Bridging the Gaps in Brain Mets

8 months ago

Jason Mouabbi, MD(+2 more)

1:58

Lingering Questions on the Earlier Use of Oral SERDs in ER+ Breast Cancer

8 months ago

Seth Wander, MD, PhD

1:02

Dr Singhi on the Emerging Role of TROP2-Directed ADCs in the Evolving Treatment Algorithm of NSCLC

8 months ago

Eric K. Singhi, MD

1:04

Clinical Decision-Making Around Local vs Systemic Therapy for Metastatic Lung Cancer With CNS-Only Disease

8 months ago

Laura Alder, MD

1:10

Patient-Level Clinical Trial Communication Skills For Hematology/Oncology Fellows

8 months ago

Carma L. Bylund, PhD

1:52

ASCO GI 2026 Highlights

8 months ago

0:45

The Use of Measurements in Oncology to Define Clinical Utility

8 months ago

Maurie Markman, MD

0:57

FDA Approval of Enfortumab Vedotin Plus Pembrolizumab for Cisplatin-Ineligible MIBC

8 months ago

Christof Vulsteke, MD, PhD

1:09

AI-Powered Tools May Accelerate Developments in Precision Oncology for GI Cancer

8 months ago

William A. Hall, MD

0:50

Anderson Underscores Benefits of Daratumumab Combination in MRD-Postitive Multiple Myeloma

8 months ago

Larry Anderson, MD, PhD

Stephen Lam Chan, MBBS, MD (CUHK), FRCP,

1:04

RFS Outcomes With Adjuvant Pembrolizumab vs Placebo After Complete Radiological Response in HCC

8 months ago

Stephen Lam Chan, MBBS, MD

1:08

Hahn Highlights The Promise of Angiogenesis Targeted Therapies in RCC

8 months ago

Andrew W. Hahn, MD

0:21

Hirbe Previews Exciting Progress With Predictive Biomarker Research at SNO 2025

10 months ago

Angela C. Hirbe, MD, PhD

0:25

Schaff Spotlights Key Research in Leptomeningeal Metastases at SNO 2025

10 months ago

Lauren Shaff, MD

1:38

20th Annual New York Lung Cancers Symposium

10 months ago

Benjamin Herzberg, MD(+3 more)

0:57

Unpacking Data From the Phase 3 ROSELLA Study

10 months ago

Vanda Salutari, MD

0:32

The Significance of OptiTROP-Lung04 for TROP-2 ADCs in Lung Cancer

10 months ago

Pasi A. Jänne, MD, PhD

1:34

Precision Strategies and Targeted Combinations in GU Oncology From ESMO 2025

10 months ago

Andrea Necchi, MD(+1 more)

1:32

Breaking Down the Surgical Management of Known Metastatic Cancer

10 months ago

Maurie Markman, MD

Video Shorts

Trending on OncLive

ASCO Issues First Living Guideline for Systemic Treatment of Recurrent Ovarian Cancer

OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer

FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer

The OncFive: Top Oncology Articles for the Week of 9/14/2026

OncLive Weekly News Quiz (9/19/2026): Did You Catch the Latest NETs, Lung, Mastocytosis, and Pancreatic Cancer News?